| 16533424 | Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy. | Neoplasia | 2006 Jan | Chekerov R | - |
| 19111388 | Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis. | Cancer Lett | 2009 Apr 18 | Coss A | doi: 10.1016/j.canlet.2008.11.018 |
| 26617887 | Multidrug resistance protein and topoisomerase 2 alpha expression in non-small cell lung cancer are related with brain metastasis postoperatively. | Int J Clin Exp Pathol | 2015 Sep 1 | Huang H | - |
| 23398928 | Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer. | J Transl Med | 2013 Feb 11 | de Resende MF | doi: 10.1186/1479-5876-11-36. |
| 21435434 | Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization. | Am J Pathol | 2011 Apr | Romero A | doi: 10.1016/j.ajpath.2010.12.042. |
| 28231233 | Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese. | Med Sci Monit | 2017 Feb 23 | Wang TL | - |
| 25237769 | TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer. | Oncotarget | 2014 Oct 15 | Li X | - |
| 12237772 | DNA topoisomerase I and II expression in drug resistant germ cell tumours. | Br J Cancer | 2002 Sep 9 | Berney DM | - |
| 24624938 | Expression of topoisomerase II alpha, ki67, and p53 in primary non-muscle-invasive urothelial bladder carcinoma. | J Immunoassay Immunochem | 2014 | Ben Abdelkrim S | doi: 10.1080/15321819.2014.899254. |
| 21506336 | [Topoisomerase IIalpha activity and tumor cell proliferation level from the degree of bromodeoxyuridine label in uterine body leiomyosarcoma]. | Arkh Patol | 2011 Jan-Feb | Lazarev AF | - |
| 21614903 | The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors. | Eur J Gynaecol Oncol | 2011 | Panousis D | - |
| 26046674 | EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells. | Sci Rep | 2015 Jun 5 | Li Y | doi: 10.1038/srep11009. |
| 19539329 | Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy. | J Urol | 2009 Aug | Albadine R | doi: 10.1016/j.juro.2009.03.078 |
| 21734419 | Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer. | Oncology | 2011 | Nikol??nyi A | doi: 10.1159/000329038 |
| 19019771 | Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables. | Am J Clin Pathol | 2008 Dec | Shvero J | doi: 10.1309/AJCPROG61USKCBEI. |
| 28692049 | Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53. | Oncogene | 2017 Nov 2 | Senturk JC | doi: 10.1038/onc.2017.229 |
| 26867764 | A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. | BMC Cancer | 2016 Feb 11 | Tarpgaard LS | doi: 10.1186/s12885-016-2124-5. |
| 21288332 | Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers. | Breast Cancer Res | 2011 Feb 2 | Lamy PJ | doi: 10.1186/bcr2824. |
| 24388441 | Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. | Eur Urol | 2014 Nov | Parker AS | doi: 10.1016/j.eururo.2013.12.017 |
| 22374418 | Topoisomerase 2 alpha: a real predictor of anthracycline efficacy? | Clin Transl Oncol | 2012 Mar | Romero A | doi: 10.1007/s12094-012-0779-1. |
| 16864174 | TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer. | Acta Oncol | 2006 | Villman K | - |
| 19270648 | Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. | Mod Pathol | 2009 Apr | Faggad A | doi: 10.1038/modpathol.2009.14 |
| 19913893 | Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer. | Urology | 2010 Jun | Kim EJ | doi: 10.1016/j.urology.2009.08.055 |
| 19729798 | Metastatic breast cancer survival according to HER2 and Topo2a gene status. | Dis Markers | 2009 | Todorovi-Rakovi N | doi: 10.3233/DMA-2009-0628. |
| 16271071 | Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha. | Cancer Sci | 2005 Nov | de Lucio B | - |
| 26588239 | Evaluation of TOP2A as a Predictive Marker for Endometrial Cancer With Taxane-Containing Adjuvant Chemotherapy. | Int J Gynecol Cancer | 2016 Feb | Ito F | doi: 10.1097/IGC.0000000000000607. |
| 28079792 | Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer. | Medicine (Baltimore) | 2017 Jan | Chen JR | doi: 10.1097/MD.0000000000005582. |
| 24675496 | Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer. | Tumori | 2014 Jan-Feb | Won HS | doi: 10.1700/1430.15820. |
| 14991576 | Coamplified and overexpressed genes at ERBB2 locus in gastric cancer. | Int J Cancer | 2004 Apr 20 | Varis A | - |
| 24682655 | HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics. | Breast Cancer Res Treat | 2014 May | Fasching PA | doi: 10.1007/s10549-014-2922-x |
| 21667123 | ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer. | Breast Cancer Res Treat | 2012 Apr | Jensen JD | doi: 10.1007/s10549-011-1610-3 |
| 25846735 | Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer. | Tumour Biol | 2015 Sep | Qiao JH | doi: 10.1007/s13277-015-3390-6 |
| 21629784 | A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer. | PLoS One | 2011 | Malhotra S | doi: 10.1371/journal.pone.0020293 |
| 22076611 | DNA topoisomerase II alpha: a favorable prognostic factor in colorectal caner. | Int J Colorectal Dis | 2012 Apr | Gao XH | doi: 10.1007/s00384-011-1346-x |
| 27175798 | Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care. | J Biomed Sci | 2016 May 12 | Peres AL | doi: 10.1186/s12929-016-0258-z. |
| 22426810 | Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer. | Pathol Oncol Res | 2012 Oct | Zaczek A | - |
| 18332872 | Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. | Lab Invest | 2008 May | Arriola E | doi: 10.1038/labinvest.2008.19 |
| 21875466 | [Correlation of TOP2A gene expression and survival of breast cancer patients]. | Zhonghua Zhong Liu Za Zhi | 2011 May | Meng H | - |
| 25304659 | Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer. | World J Surg Oncol | 2014 Oct 11 | Yu P | doi: 10.1186/1477-7819-12-307. |
| 22569122 | Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells. | Neurosci Lett | 2012 Jun 19 | Hong Y | doi: 10.1016/j.neulet.2012.04.071 |
| 16234514 | retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group. | J Clin Oncol | 2005 Oct 20 | Knoop AS | - |
| 21705665 | TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancer. | Oncologist | 2011 | Glynn RW | doi: 10.1634/theoncologist.2011-0071 |
| 14566826 | HER-2 and TOP2A coamplification in urinary bladder cancer. | Int J Cancer | 2003 Dec 10 | Simon R | - |
| 20079182 | [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro]. | Zhonghua Fu Chan Ke Za Zhi | 2009 Sep | He J | - |
| 20441774 | Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples. | Clin Biochem | 2010 Jul | Zaczek A | doi: 10.1016/j.clinbiochem.2010.04.060 |
| 21455636 | Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. | Pathol Oncol Res | 2011 Sep | Rijavec M | doi: 10.1007/s12253-011-9370-2 |
| 25042383 | Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer. | Pathol Res Pract | 2014 Oct | Almeida D | doi: 10.1016/j.prp.2014.06.017 |
| 26560244 | Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression. | PLoS One | 2015 Nov 11 | Schaefer-Klein JL | doi: 10.1371/journal.pone.0142327 |
| 24630889 | MCM2/TOP2A (ProExC) immunohistochemistry as a predictive marker in head and neck mucosal biopsies. | Pathol Res Pract | 2014 Jun | Jenson EG | doi: 10.1016/j.prp.2014.02.003 |
| 19661040 | A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers. | Clin Breast Cancer | 2009 Aug | Yerushalmi R | doi: 10.3816/CBC.2009.n.027. |
| 28075472 | Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways. | Oncol Rep | 2017 Feb | Yang Z | doi: 10.3892/or.2017.5358 |
| 18465341 | The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D. | Acta Oncol | 2008 | Nielsen KV | doi: 10.1080/02841860801995396. |
| 25846551 | Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study. | Ann Oncol | 2015 Jul | Beltrame L | doi: 10.1093/annonc/mdv164 |
| 26252353 | RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients. | Oncol Rep | 2015 Oct | Xu YC | doi: 10.3892/or.2015.4183 |
| 25921160 | Sensitivity of gastric cancer cells to chemotherapy drugs in elderly patients and its correlation with cyclooxygenase-2 expression. | Asian Pac J Cancer Prev | 2015 | Qiu ZQ | - |
| 18824850 | Somatostatin elevates topoisomerase II alpha and enhances the cytotoxic effect of doxorubicin on gallbladder cancer cells. | Chemotherapy | 2008 | Quan ZW | doi: 10.1159/000158662 |
| 20130985 | Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer. | Breast Cancer Res Treat | 2010 Apr | Konecny GE | doi: 10.1007/s10549-010-0744-z |
| 25098819 | Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17. | PLoS One | 2014 Aug 6 | Kotoula V | doi: 10.1371/journal.pone.0103707 |
| 21519837 | Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial. | Breast Cancer Res Treat | 2011 Jul | O'Malley FP | doi: 10.1007/s10549-011-1511-5 |
| 22706628 | TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer. | Breast Cancer Res Treat | 2012 Jul | Sparano JA | doi: 10.1007/s10549-012-2112-7 |
| 26022247 | Allelic imbalance at the HER2/TOP2A locus in breast cancer. | Diagn Pathol | 2015 May 29 | Huijsmans CJ | doi: 10.1186/s13000-015-0289-x. |
| 24138107 | Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancer. | Scand J Gastroenterol | 2013 Dec | Nygrd SB | doi: 10.3109/00365521.2013.848230 |
| 20089371 | The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapy. | Pathol Res Pract | 2010 Mar 15 | Kawachi K | doi: 10.1016/j.prp.2009.10.009 |
| 25550836 | Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer. | Int J Clin Exp Pathol | 2014 Oct 15 | Yu P | - |
| 15375522 | Prognostic value of Topoisomerase II in female breast cancer. | Oncol Rep | 2004 Oct | Koren R | - |
| 22555090 | Her-2/neu and topoisomerase IIα in advanced breast cancer: a comprehensive FISH analysis of 245 cases. | Diagn Mol Pathol | 2012 Jun | Engelstaedter V | doi: 10.1097/PDM.0b013e31823b6e43. |
| 28393224 | Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer. | Oncol Rep | 2017 May | Dimas-Gonz??lez J | doi: 10.3892/or.2017.5553 |
| 27284123 | Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer. | Int J Surg Pathol | 2016 Oct | ahin S | doi: 10.1177/1066896916653211 |
| 27558965 | RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation. | Nat Commun | 2016 Aug 25 | Guturi KKN | doi: 10.1038/ncomms12638. |
| 29587760 | The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer. | BMC Cancer | 2018 Mar 27 | An X | doi: 10.1186/s12885-018-4170-7. |
| 29330624 | Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer. | Breast Cancer Res Treat | 2018 Apr | Nuncia-Cantarero M | doi: 10.1007/s10549-017-4652-3 |
| 30132517 | DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride. | Int J Oncol | 2018 Nov | Liu LM | doi: 10.3892/ijo.2018.4531 |
| 30760286 | TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers. | J Ovarian Res | 2019 Feb 13 | Ghisoni E | doi: 10.1186/s13048-019-0492-6. |
